Cellectar Biosciences Inc... (CLRB)

AI Score

Unlock

0.26

-0.03 (-11.32%)

At close: Apr 04, 2025, 3:59 PM

0.26

-0.36%

After-hours: Apr 04, 2025, 05:44 PM EDT

Cellectar Biosciences Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004
Cash & Equivalents	23.29M	9.56M	19.87M	35.7M	57.17M	10.61M	13.26M	10.01M	11.44M	3.86M	9.42M	2.42M	4.68M	5.51M	2.37M	8.77M	1.26M	9.74M	9.94M	4.27M	10.36K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	55K	55K	55K	55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.35K	15.35K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	29.78K	29.78K	81.21K	81.21K	81.21K	81.21K	558.91K	11.87K	11.87K	11.87K	11.87K	11.87K	2.03M	27.22K	n/a	n/a	15.35K	15.35K	10.88K	114.16K	6K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.58K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	961.66K	888.23K	663.24K	867.49K	774.43K	770.95K	55K	933K	55K	55K	55K	55K	125.54K	55K	63.53K	102.92K	129.78K	1.18M	1.66M	196.91K	79.63K
Total Current Assets	24.25M	10.45M	20.53M	36.57M	57.94M	11.39M	13.95M	10.94M	12.19M	4.18M	9.7M	2.77M	5.13M	5.82M	2.44M	8.87M	1.39M	11.06M	11.89M	4.8M	102.57K
Property-Plant & Equipment	1.19M	1.59M	978.98K	549.13K	638.35K	783.92K	543.34K	244.71K	1.44M	1.73M	2.03M	2.36M	2.65M	3.04M	8.76K	44.1K	58.45K	32.81K	23.81K	22.61K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.68M	1.68M	1.68M	1.68M	1.68M	1.68M	1.68M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.22M	1.62M	1.06M	630.35K	719.56K	865.14K	1.1M	1.93M	3.13M	3.42M	3.72M	4.05M	6.35M	4.75M	24.11K	59.45K	73.8K	48.16K	34.69K	136.77K	6K
Total Assets	25.47M	12.08M	21.59M	37.2M	58.66M	12.25M	15.05M	12.87M	15.32M	7.6M	13.42M	6.82M	11.48M	10.56M	2.46M	8.93M	1.47M	11.11M	11.92M	4.94M	108.57K
Account Payables	611K	5.62M	2.56M	1.42M	1.43M	1.28M	612K	933K	1.42M	635.92	580.99	1.16K	716.99K	478.04K	392.88K	3.3M	4.65M	6.37M	1.09M	211.46K	2.03M
Deferred Revenue	n/a	n/a	n/a	2.44M	2.01M	1.39M	965.09K	-1.87M	-1.42M	-635.92	-580.99	-1.16K	n/a	n/a	33.33K	33.33K	33.33K	n/a	n/a	n/a	n/a
Short-Term Debt	84.42K	n/a	50.85K	135.45K	n/a	105.89K	2.21K	3.04K	89.32K	246.04K	122.1K	1.69K	2.4K	2.23K	n/a	n/a	n/a	n/a	n/a	n/a	2.02M
Other Current Liabilities	8.69M	18.19M	1.95M	368.46K	0.00	288.99K	481.7K	1.18M	124.4K	5.45M	2.06M	4.52M	10.91K	21.07K	153.96K	10.49M	n/a	n/a	n/a	n/a	397.61K
Total Current Liabilities	9.39M	25.36M	5.53M	3.99M	3.56M	2.77M	1.62M	2.11M	1.63M	5.7M	2.18M	4.52M	732.69K	503.58K	887.31K	16.97M	6.62M	7.06M	1.31M	217.16K	4.44M
Long-Term Debt	409.59K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	86.63K	330.08K	450K	450K	450K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.38M	n/a	n/a	n/a	n/a	n/a	171K	n/a	146.58K	148.92K	147.77K	143.23K	135.4K	n/a	-6.33K	18.46M	n/a	9.92M	n/a	n/a	1.14K
Total Long-Term Liabilities	1.79M	494K	552.98K	166.29K	301.74K	421.64K	171K	2.21K	151.83K	243.53K	488.98K	593.23K	587.1K	578.47K	366.67K	18.86M	433.33K	9.92M	n/a	n/a	13.73K
Total Liabilities	11.18M	25.85M	6.08M	4.16M	3.86M	3.19M	1.79M	2.12M	1.78M	5.95M	2.67M	5.12M	1.32M	1.08M	1.25M	35.83M	7.05M	16.98M	1.31M	217.16K	4.46M
Total Debt	494K	552.98K	603.83K	301.74K	421.64K	527.53K	2.21K	5.25K	94.57K	340.65K	463.31K	451.69K	454.09K	456.33K	n/a	n/a	n/a	n/a	n/a	n/a	2.02M
Common Stock	461.00	207.00	94.00	611.00	454.00	94.00	47.00	167.00	104.00	9.00	76.00	574.00	464.00	369.00	4.53K	697.00	440.00	392.00	392.00	279.00	44.00
Retained Earnings	-247.34M	-217.48M	-179.5M	-150.9M	-126.78M	-111.68M	-97.59M	-84.35M	-70.79M	-64.61M	-59.17M	-51.06M	-40.28M	-31.48M	-73.98M	-76.07M	-59.69M	-43.24M	-23.68M	-15.4M	-12.35M
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	-0.00	-0.00	n/a	n/a	-2.46M	-18.46M	n/a	-9.92M	n/a	n/a	n/a
Shareholders Equity	14.29M	-15.16M	15.51M	33.05M	54.79M	9.06M	13.26M	10.75M	13.54M	1.65M	10.75M	1.7M	10.16M	9.48M	1.21M	-26.9M	-5.58M	-5.87M	10.61M	4.72M	-4.35M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	55K	55K	55K	55K	n/a	n/a	n/a	n/a	15.35K	15.35K	n/a	n/a	n/a	n/a	n/a